Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
Oral contraceptive use and clinical outcomes in patients with multiple sclerosis.
The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry.
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis.
Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles.
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.
The role of mitochondria in axonal degeneration and tissue repair in MS.
IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability.
Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis.
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature.
Dimethyl fumarate (Tecfidera) for multiple sclerosis.
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain.
European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil.
The natural course of clinically isolated syndrome in pediatric patients.
Variables associated with patient activation in persons with multiple sclerosis.
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.
Significance of Virchow-Robin Spaces in Patients Newly Diagnosed with Multiple Sclerosis: A Case-Control Study in an Arab Population.
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?

Pages